A full panel for diagnosis, classification and monitoring of patients with acute leukemia
A step In The Right Direction
• Acute leukemias are a heterogeneous group of malignancies with varying clinical, morphologic, immunologic and molecular characteristics
• Many distinct types are known to carry predictable prognosis and warrant specific therapy
• Distinction between lymphoid and myeloid leukemias, most often made by flow cytometry is crucially important
• Multiparameter flow cytometry is an invaluable tool in the diagnosis, classification and monitoring of patients with acute leukemia
• Ansary labs introduces the newest generation of the BD Accuri™ platform with enhanced sensitivity & reliability
